Phase II
Several initiatives are under way to prepare for the resumption of construction. Marketing and leasing efforts are continuing, as are activities necessary to acquire the remaining permits for construction.
MaRS continues to thrive. The MaRS Centre is oversubscribed with a growing list of tenant prospects. The MaRS team is providing high quality advisory services and educational programming to young companies in MaRS and to science, technology and social entrepreneurs in its extended community.
Read more:
- "Recession gives pause to innovation centre" - John Barber, Globe and Mail
- "The halting road to new discoveries" - Jeff Gray, Glove and Mail
In June 2007, MaRS announced that it had selected Alexandria Real Estate Equities, Inc. (NYSE: ARE), North America’s pre-eminent, first-in-class and largest life science property specialist, as the development partner for an iconic new building which will anchor the city’s biomedical corridor in the Discovery District of Toronto. To be developed on a prominent street corner in Toronto at University Avenue and College Street, the building is adjacent to the seat of the provincial government, cultural and financial districts, and world-class academic and clinical research institutions. In this exceptional location, Alexandria will apply its renowned expertise in developing clusters, including its proprietary programmatic elements, to strengthen Toronto’s growing life science and technology cluster centered in the Discovery District. The influence and impact of MaRS on the local community, greater Ontario and Canada will grow exponentially through the strategic alliance with Alexandria.
PICTURES
Nearly 400 guests joined the Premier of Ontario, Mayor of Toronto and other dignitaries on June 26, 2007 to celebrate the announcement of MaRS' spectacular Phase II development with California-based Alexandria Real Estate Equities Inc.| Prevous image | 1 | / | 4 | Next image |
View more Phase II announcement photos on Flickr
VIDEOS
ABOUT ALEXANDRIA
ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE:NYSE) is the largest owner and pre-eminent first-in-class international real estate operator focused principally on the ownership, operation, redevelopment, selective development and acquisition of properties containing office and laboratory space. Alexandria is the leading provider of real estate to the life science industry and has an outstanding almost ten-year track record as a NYSE listed company with an approximate $5.2 billion total market capitalization as of March 31, 2007. Alexandria provides high quality real estate, technical infrastructure, services, and capital to the broad and diverse life science sector. Client tenants include universities and not-for-profit institutions, pharmaceutical, biotechnology, medical device, life science product, service and translational research entities, as well as governmental agencies. Alexandria’s international operating platform is based on the principle of "clustering" with assets and operations strategically located and dominant in each key life science cluster submarket.For Alexandria Real Estate Equities, Inc.
Judith Sylk-Siegel
Rx Communications Group
917-322-2164
jsylksiegel@rxir.com
PRESS RELEASES
 | Press Release [119 KB] |
BROWSE PAGES
MaRS FACTS
The MaRS Incubator currently houses 27 emerging companies in fields such as life sciences, communications, information technology and advanced materials.MaRS BLOG
